Target- |
MechanismImmunostimulants |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc. |
First Approval Date04 Aug 2000 |
100 Clinical Results associated with Evans Vaccines Ltd.
0 Patents (Medical) associated with Evans Vaccines Ltd.
100 Deals associated with Evans Vaccines Ltd.
100 Translational Medicine associated with Evans Vaccines Ltd.